| ²é¿´: 579 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
Öò¹âÀïµÄ΢Цгæ (ÕýʽдÊÖ)
|
[½»Á÷]
ÇóÖú£ºÒ»¾ä»°·Òë
|
||
| ·ÖÎöĿǰ¼×°±µûßÊѪҩŨ¶È²â¶¨µÄ·½·¨£¬Ñ°ÕÒ×ʹÓõķÖÎö·½·¨¼°Óë¸Ã·½·¨Ïà¶ÔÓ¦µÄ·ÖÎöÌõ¼þ£¬ÎªTDxFLx/TDxÃâÒß·ÖÎöÒÇÅäÌ×ÊÔ¼ÁºÐÍ£²úºóÌṩ¿É¹©Ñ¡ÔñµÄ¼×°±µûßÊѪҩŨ¶È²â¶¨·½·¨¡£ |
» ²ÂÄãϲ»¶
¿É¿¿ÏûÏ¢£¬8ÔÂ21ºÅ(Ã÷Ìì)·Å°ñ
ÒѾÓÐ3È˻ظ´
Ö»ÓÐÿÄêÕâÖÖʱºòÀ´¹ä¹äСľ³æ
ÒѾÓÐ20È˻ظ´
»¶Ó·¢À´filecodeµÄMz6ºóµÄ´úÂëÑéÖ¤Æä¹æÂÉ
ÒѾÓÐ125È˻ظ´
½ñÌì»ù½ð»á³ö½á¹ûÂð£¿20260819
ÒѾÓÐ15È˻ظ´
ʱ¼ä´Á±äÁË£¬ÄÜ¿´³öʲôÎÊÌ⣿
ÒѾÓÐ16È˻ظ´
filecode£¬4¸öjtjcÁË
ÒѾÓÐ13È˻ظ´
ΪʲôÓà¶î±¦µÄÄ껯ÀûÂÊÔ½À´Ô½µÍ£¿Ö÷ÒªÔÒòÓÐÄÄЩ£¿
ÒѾÓÐ5È˻ظ´
½ñÌì·Å°ñûϷÁ˰É
ÒѾÓÐ5È˻ظ´
½ñÌì·Å°ñÂð£¿
ÒѾÓÐ15È˻ظ´
filecode=ºóÃæµÚÒ»¸öÊÇ´óд×Öĸ
ÒѾÓÐ12È˻ظ´
zerohead
½û³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 466
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ¹ó±ö: 0.301
- ½ð±Ò: 8727.8
- É¢½ð: 850
- ºì»¨: 15
- ɳ·¢: 10
- Ìû×Ó: 3768
- ÔÚÏß: 471.7Сʱ
- ³æºÅ: 1041741
- ×¢²á: 2010-06-14
- ÐÔ±ð: GG
- רҵ: Â߼ѧ
Öò¹âÀïµÄ΢Ц(½ð±Ò+3, ·ÒëEPI+1): 2010-08-12 15:27:13
|
Ä¿µÄ ·ÖÎöĿǰ¼×°±µûßÊѪҩŨ¶È²â¶¨µÄ·½·¨£¬Ñ°ÕÒ×ʹÓõķÖÎö·½·¨¼°Óë¸Ã·½·¨Ïà¶ÔÓ¦µÄ·ÖÎöÌõ¼þ£¬ÎªTDxFLx/TDxÃâÒß·ÖÎöÒÇÅäÌ×ÊÔ¼ÁºÐÍ£²úºóÌṩ¿É¹©Ñ¡ÔñµÄ¼×°±µûßÊѪҩŨ¶È²â¶¨·½·¨¡£ Objectives: To evaluate the currently used methods for determining blood concentration of methotrexate, and find out the most frequently used analytical method and the corresponding testing conditions. To provide another choice of determining blood concentration of methotrexate after the termination of reagent production for the TDxFLx/TDx immunoassay. |
2Â¥2010-08-12 15:22:35









»Ø¸´´ËÂ¥